12 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Pediatric Infectious Diseases Society Fellowship Award
Completed applications for the Pediatric Infectious Diseases Society Fellowship Award must be received by March 7, 2014 for the award cycle that begins on July 1, 2014.
Goals: The goal of the Fellowship Awards is to help increase the pool of highly trained pediatric infectious disease clinical scientists and to stimulate scholarly basic and clinical research in the following areas pertinent to pediatrics: public health/epidemiology, hospital epidemiology, clinical trials of antimicrobials, outcomes research, pharmacokinetics, pathophysiology, molecular pathogenesis, research related to vaccine development, and other topics of relevance to pediatric infectious diseases.
NOTE: The Society encourages applications for clinically applied/translational research.
Eligibility: Candidates must possess a MD or MD/PhD and be at least a first-year fellow in a Pediatric Infectious Diseases program in North America at the time of application. The award will be given for two subsequent years of training, during which time the applicant is expected to devote the major portion (at least 75% of time) of those years conducting the proposed research project under the direct supervision of a mentor who must be a PIDS member in good standing for at least one year.
Support: The annual stipend will be $45,000 and will be given for two years, subject to review at the end of the first year. In the case of awards given to a candidate in the final year of fellowship, only one year of the award will be given to the recipient. The stipend is intended to provide salary and benefits for the fellow. It is not intended to provide resources for a division's research program, nor to pay indirect costs of the institution.
Application and Selection Process: Application materials must be received by 5:00 pm EST on Friday, March 7, 2014. Electronic submission is strongly preferred.
International Society for Infectious Diseases Small Grants Program
The Small Grants Program is designed to fund pilot research projects by young investigators living and working in developing countries. The goal is to support and foster the professional development of young individuals (less than 40 years of age) in the field of human infectious diseases research by helping them to acquire additional skills and data to apply for other grants. Areas of interest include, but are not limited to investigations of the epidemiology, pathophysiology, diagnosis or treatment of infectious diseases, the epidemiology and control of hospital-acquired infections, and modeling of cost effective interventions.
Proposals will be reviewed by members of the Professional Development Working Group and decisions made in collaboration with the President and the Program Director.
Upon completion of the project, a written report of the project must be sent to the Society. The Society encourages recipients of grants to present their results at scientific meetings and to submit them for publication in peer-reviewed journals.
Up to eight grants of up to US $6,000 each will be awarded annually. The deadline for submission of proposals is April 1 (notification after June 1).
Requests for application materials and additional information should be directed to:
ISID Professional Development Working Group
9 Babcock Street, Unit 3
Brookline, Massachusetts 02446
Fax: (617) 278-9113
Society for Vascular Nursing Research Grant
All applicants for project/research support should submit requests on the Research Grant Application Form
for merit comparison of proposals. The applicant and the institution are required to affirm that satisfactory ethical precautions shall be taken with regard to projects involving human subjects as described in the guidelines. All applications shall be reviewed by the Vascular Nursing Research Grant Subcommittee of the Research Committee of the Society for Vascular Nursing.
The deadline for submitting an application for the 2014 SVN Research Grant has been extended until March 15, 2014.
The project coordinator/principal investigator (PC/PI) has scientific responsibilities for the conduct of the proposed clinical project/research and assumes responsibility for supervising such assistants as may be required. The PC/PI, along with the institution’s fiscal officer (when indicated), is also responsible for the expenditure and proper reporting of awarded funds.
The PC/PI must be a registered, professional nurse (RN).
Any PC/PI applicant without a Master of Science in Nursing (MSN) or a master’s degree in a related field must identify a nursing research consultant prepared at the master’s level or above who shall provide guidance throughout the project.
Top twenty vascular nursing research priorities
1. Strategies to increase public awareness of the signs and symptoms of vascular disease.
2. Strategies to increase public awareness of stroke warning signs.
3. Strategies to increase early detection and treatment of vascular disease.
4. Strategies to prevent amputation in high risk populations
5. Outcomes of patients cared for on a dedicated vascular unit vs. a medical-surgical unit.
6. Strategies to educate the public to help prevent the development of vascular disease.
7. Strategies to increase public awareness on the adverse effects of uncontrolled diabetes.
8. Strategies to manage chronic ischemic pain.
9. Strategies to reduce healthcare costs and length of stay while improving outcomes.
10. Nurse’s role in vascular ulcer prevention, identification, treatment, and education.
11. Strategies to increase diabetic patient compliance with diet, exercise, and glucose control.
12. Strategies to prevent wound and postoperative incision infections.
13. Outcomes of nurse-run clinics.
14. Effect of exercise on claudication symptoms.
15. Strategies to increase patient’s knowledge of venous ulcer prevention.
16. What is the patient’s understanding of discharge instructions after vascular surgery?
17. Nursing strategies to facilitate recovery after vascular surgery.
18. Factors that affect patient outcomes after major vascular procedures.
19. Prevention of readmissions in high risk patients.
20. Prevention of deep vein thrombosis in high risk patients.
Emergency Medicine Foundation/EMRA Critical Care Resident Research Grant
Deadline for receipt of application - January 10, 2014
The Emergency Medicine Foundation awards funds to support the development of research in emergency medicine. The goals of the EMF/EMRA Critical Care Resident Research Program are: 1) to promote research within the specialties of emergency medicine and critical care, 2) to advance care for the critically ill in the emergency department and beyond, and 3) to facilitate the academic growth and development of future researchers and leaders in emergency medicine-critical care and thereby invest in the future of the growing specialty of emergency medicine-critical care.
The EMF/EMRA Critical Care Resident Research Grant attempts to maximize the applicant's educational experience in research while producing the best science. The educational agenda is best accomplished in an organized program of instruction on research methods in addition to the completion of the project itself.
A maximum of $5,000 will be awarded for each approved grant application. Funds are not to be used for capital equipment purchases, faculty salary support, publication costs, travel, or institutional overhead.
DEFINITION OF EMERGENCY MEDICINE-CRITICAL CARE RESEARCH
Emergency medicine-critical care research is broadly defined as scientific investigation designed to furnish new knowledge relating to resuscitation science and/or the care of critically ill patients across multiple venues including the prehospital setting, the emergency department, and the intensive care unit. Such investigations or innovations may focus on basic science research, clinical research, epidemiology, health care policy, or teaching and education.
QUALIFICATIONS AND RESPONSIBILITIES OF THE INVESTIGATORS
EMF Resident Research Grants are available to any physician who will be enrolled as a resident in good standing in an ACGME or AACOM approved emergency medicine residency for the proposed funding year. The resident must have a faculty preceptor who is capable of ensuring the successful completion of the proposed project. A resident may competitively apply in succeeding years for other projects.
It is required that the applicant submit a letter of support from a preceptor at the applicant's institution. This letter must describe the preceptor's and the resident's roles and responsibilities in the proposed project. The preceptor must hold a have and MD, DO, PhD or equivalent degree. The preceptor must have proven ability to pursue independent research as evidenced by original research publications in peer-reviewed journals and/or funding from extramural sources. The preceptor may be in any department within the applicant's institution.
The applicant and preceptor assume responsibility for conducting the research projects and supervising the work of the resident and associate investigators. The applicant and preceptor must demonstrate that access to a suitable caseload or patient population will be available for study during the funding period if a clinical research project is proposed. If a basic science or nonclinical project is proposed, the applicant must show that adequate and appropriately equipped laboratory space will be available during the funding period. Research involving animals or human subjects must be approved by the institutional review board (IRB), or its equivalent, and a copy of the approval or pending approval sent with this application. IRB approval must be documented prior to dispensation of EMF funds. Letters of support from the Emergency Medicine Chair and Residency Director are required.
EVALUATION OF APPLICATIONS
Each application will be reviewed by emergency medicine or critical care specialists who are involved/informed in basic and clinical emergency medicine research. Each application will be judged by: 1) the educational experience for the resident, including a program of instruction on research methods and the format for evaluating the progress of the award year, 2) the role of the resident applicant in the initiation, development, conduct, and reporting of the project, 3) the scientific content of the research projects, including background support, hypothesis statement, methodology, sample size calculations and planned statistical analysis, 4) the significance of the project, and 5) the qualifications of the preceptor. There should be an acknowledgement that the resident is the author of the grant application. The final funding decision will be made by the Emergency Medicine Foundation Board of Trustees, and all decisions are final.
Emergency Medicine Foundation/Emergency Nurses Association Foundation Directed Team Grant Research Award
Deadline for receipt of application: January 10, 2014
The Emergency Medicine Foundation and the ENA Foundation jointly award this grant to facilitate collaboration between the disciplines and to improve clinical research in emergency care. This grant is intended for physician and nurse researchers to combine their expertise to develop, plan, and implement clinical research in emergency care.
The EMF/ENA Foundation Directed Team Grant Research Award program awards one $50,000 grant for research over a one year period.
PURPOSE OF THE EMF/ENA FOUNDATION DIRECTED TEAM GRANT RESEARCH AWARD
This grant exists because of the donation of funds by both the Emergency Medicine Foundation and the ENA Foundation. It was funded specifically to support work that arises from a true physician-nurse partnership in a clinical research area pertinent to the practice of emergency medicine. As such, the applicants must provide evidence of a true collaborative effort between physician and nurse professionals and must delineate the relative roles of the participants in terms of protocol development, data collection, and manuscript preparation.
This request for proposals specifically seeks research related to the topic of ED overcrowding and ED workplace violence. Proposals may focus on a number of related areas, including: definitions and outcome measures of ED overcrowding, causes and effects of ED overcrowding, potential solutions to the problem of ED overcrowding, the scope and problem of ED workplace violence, definitions and metrics for measuring ED workplace violence, and projects that address coping with workplace violence.
Applications will be accepted from any emergency medicine physician/nurse team working full or part time in emergency care at any domestic, Joint Commission-accredited institution. The nurse principal investigator must:
• Be a current Emergency Nurses Association (ENA) member
• Not have served on the ENA board of directors, ENA Foundation board of trustees, or ENA Foundation grant review team in the immediate past three years
The applicants must demonstrate that access to suitable caseload, patient population or database will be available for study during the funding period. The applicants must submit letters of support from their director/chair stating that adequate funds and release time will be available. Research involving human subjects must be approved by the institutional review board (IRB), or its equivalent, and a copy of the approval or pending approval sent with this application. IRB approval must be documented prior to dispensation of EMF funds.
Emergency medicine specialists who are actively involved in clinical or health services emergency medicine research will review each application. The review committee will be comprised of members of the Scientific Review Committee of the American College of Emergency Physicians (this committee performs peer review for EMF) and members of the ENA Foundation. Each application will be judged according to 1) significance to the topic of ED overcrowding or ED workplace violence, 2) demonstration of a collaborative effort between physician and nurse researchers along with the applicants’ background, commitment, and potential as a researchers in emergency medicine, 3) the scientific merit, methodology and originality of the research project, 4) appropriateness of budget, and 5) the documented willingness of the sponsoring institution to provide the necessary facilities and support to complete the projects as described. Additional elements that contribute to the score will be project feasibility and the clear statement of measurable aims. Feasibility may be enhanced by inclusion of appropriate hospital administrative leaders. Purely descriptive projects or surveys are unlikely to be successful. Preliminary data from the research institution is highly encouraged. In constructing the project goals, applicants are encouraged to be aware of the June 14, 2006 report by the Institute of Medicine Hospital-Based Emergency Care: At the Breaking Point, and its findings relative to the impact of overcrowding in the emergency department. The final funding decision will be made jointly by the Emergency Medicine Foundation Board of Trustees and the ENA Foundation. All decisions are final.
Limitations on Awards
Funds may be used for materials, supplies, services (e.g., respiratory therapy, statistical consultation), or to provide salary support for ancillary staff (e.g., technicians, data collectors). Capital equipment expenditures (cost greater than $500 and with a life of over one year) must be justified in the budget. Payments will be made to the principal investigators’ institution that will be responsible for administering the funds. Neither the Emergency Medicine Foundation nor the ENA Foundation will be responsible for institutional overhead, cost for publications, travel, renovations, or secretarial support. Detailed audited financial reports may be required. EMF and ENA Foundation are not fiscally responsible for funds necessary for the project's completion.
Patient-Centered Outcomes Research Institute Funding Opportunity: Communication and Dissemination Research
Letter of Intent Deadline: February 1, 2014 at 5:00 pm ET
In this PCORI Funding Announcement (PFA), we seek to fund projects that address critical knowledge gaps in the communication and dissemination process—both the communication and dissemination of research results to patients, their caregivers, and clinicians, as well as the communication between patients, caregivers, and clinicians in the service of enabling patients and caregivers to make the best possible decisions in choosing among available options for care and treatment.
Total Direct Costs: $1.5 Million
Maximum Project Period: 3 Years
Applications may be submitted by:
Any private sector research organization, including any:
Any public sector research organization, including any:
University or college
Hospital or healthcare system
Laboratory or manufacturer
Unit of state or local government
All US applicant organizations must be recognized by the Internal Revenue Service. Foreign organizations and nondomestic components of organizations based in the United States may apply, as long as there is demonstrable benefit to the US healthcare system, and US efforts in the area of patient-centered research can be clearly shown. Organizations may submit multiple applications for funding. Individuals may not apply.
1. Impact of the condition on the health of individuals and populations
2. Potential for the study to improve health care and outcomes
3. Technical merit
5. Patient and stakeholder engagement
*Deadlines are at 5:00 PM ET. If deadlines fall on a weekend or a federal holiday, the deadline will be the following Monday or the next day after the federal holiday.
Patient-Centered Outcomes Research Institute Funding Opportunity: Assessment of Prevention, Diagnosis and Treatment Options
In this PCORI Funding Announcement (PFA), we seek to fund projects that address critical decisions that face patients, their caregivers, and clinicians every day without adequate information. These decisions must be consequential and be occurring now without key evidence about the comparative effectiveness of two or more options. Patients/caregivers must benefit from new knowledge in ways that are clear and important.
American Academy of Otolaryngology-Head and Neck Surgery Foundation Resident Research Grant Sponsored by The Doctors Company Foundation
The purpose of this award, which is sponsored by The Doctors Company Foundation, is to stimulate original resident research in otolaryngology that minimizes the occurrence and impact of adverse events and improves patient safety in hospital systems and out-patient settings.
Any resident of an accredited otolaryngology-head and neck surgery training program in the U.S. or Canada is eligible to apply for The Doctors Company Foundation/AAO-HNSF Resident Research Grant. All applicants must be members in good standing of AAO-HNS.
Proposed projects may be related to any area of otolaryngology, but must include a component focused on minimizing the incidence of medical errors within hospital systems and out-patient settings. Proposed projects shall be designed in collaboration with a preceptor investigator and approved by the candidate's department chairperson and institution. The results of the supported investigation must be presented at the closest AAO-HNS Foundation Annual Meeting immediately following the award. The recipient(s) shall be free to publish the results afterwards, but the Foundation shall have the right of first refusal for publication in its journal, Otolaryngology-Head and Neck Surgery. Any presentation or publication of results supported by this award shall acknowledge the contribution of The Doctors Company Foundation/AAO-HNSF Resident Research Grant. Applications must be accompanied by a letter of support from the applicant’s Department Chair verifying that the applicant will be permitted to devote an appropriate amount of time to the conduct and timely completion of the proposed research project. Resident applicants must also work with a faculty member (Preceptor) designated as a co-investigator. A letter of support must also be obtained from the co-investigator (Preceptor). Applicants must obtain letters of support/understanding from all key personnel on the project. Projects which are clinical trials of unproven drugs or devices are outside the areas of Foundation interest for purposes of resident research grants.
1. Amount: $10,000 maximum
2. Period: 12 months, non-renewable
3. Funding: One will be awarded annually from 2012 to 2016
4. Use of Funds: Award funds may be used for any legitimate costs associated with the purpose of the Award, other than salary support for the Principal Investigator. A detailed budget and budget justification constitute part of the application and will be evaluated as an important factor in the review process. If university policy stipulates that a portion of this very modest award must go toward institutional indirect costs, no more than ten percent (10%) of the total costs may be applied for indirect costs. Allowable expenses include consultant fees (e.g., statistician, methodologist); salary support for research assistants or other supporting personnel; computer software or hardware; computer database access fees; and expenses related to presentation or publication of results. Equipment and supplies purchased with this Award become the property of the recipient institution.
5. Notification: Letters of notification will be sent in June of the award year. Please do not call the office prior to this time to inquire about results.
6. Starting Date: The recipient(s) of The Doctors Company Foundation/AAO-HNSF Resident Research Grant will be announced publicly at the closest AAO-HNS Foundation Annual Meeting immediately following the award. The award may be activated as early as July 1 of the year of award, but no later than January 1 of the following year.
Applications are in a similar format to the National Institutes of Health. All applications must be completed and submitted online through ProposalCENTRAL at https://proposalcentral.altum.com.
All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time December 16, 2013.
Call for Nominations: Irving Sunshine Award
Presented for Outstanding Contributions to Clinical Toxicology
This award is presented in honor of Dr. Irving Sunshine, International Association of Therapeutic Drug Monitoring and Clinical Toxicology Honorary Member.
Terms of Reference
The Award shall be presented to an individual as a mark of recognition of outstanding contributions to Clinical Toxicology. The recipient must be a member in good standing of the Association at the day of the award presentation.
The Award shall usually be presented bi-annually, but if in the opinion of the Awards Committee no suitable candidate is available, the Award shall not be presented.
The Award shall be accompanied by a framed certificate and an honorarium in the amount of USD 1,500.
The recipient of the Award shall be chosen by the Awards Committee and approved by the IATDMCT Executive no later than four (4) months prior to the Congress at which the Award will be presented. In order to avoid a conflict of interest, the Awards Committee must no communicate with the IATDMCT Executive or Council on their selection prior to making their final decision. However, the final Awards Committee decision requires the approval of the IATDMCT Executive.
Members of IATDMCT may propose suitable candidates to the Awards Committee through the Business Office of the association.
Nominations from the membership must be accompanied by a curriculum vitae including a list of publications, and a letter from the nominator containing an evaluation and appraisal of the nominee for the award. Additional letters of support by members of the Association or other respected scientists are helpful for the Selection Committee.
The presentation of the Award shall normally be at the Opening Ceremonies of the Congress of the association. The recipient of the Award is not usually expected to give an address or present a paper.
Sponsored by Thermo Scientific
IATDMCT members are invited to nominate individuals for the IATDMCT awards. The award presentations will take place at the Opening Ceremonies of the bi-ennial Internation Congress of the IATDMCT.
How to Nominate: Nominations from members must be accompanied by curriculum vitae including a list of publications and a letter of support from the nominator containing an evaluation and appraisal of the nominee for the award. Additional letters of support from members of the Association or other respected scientists are welcomed as supporting information for the Selection Committee.
Deadline: March 31, 2015
Nominations must be received by March 31 of the Congress year.
Sander Vinks, Chair
Call for Nominations: C.E. Pippenger Award
Presented for Outstanding Contributions to Therapeutic Drug Monitoring
This award is presented in honor of Dr. C.E. Pippenger, International Association of Therapeutic Drug Monitoring and Clinical Toxicology Honorary Member.
The Award shall be presented to an individual as a mark of recognition of outstanding contributions to Therapeutic Drug Monitoring. The recipient must be a member in good standing of the Association at the day of the award presentation.
The Award shall be accompanied by a framed certificate and an honorarium in the amount of USD $1,500.
The recipient of the Award shall be chosen by the Awards Committee and approved by the IATDMCT Executive no later than four (4) months prior to the Congress at which the Award will be presented. In order to avoid a conflict of interest, the Awards Committee must not communicate with the IATDMCT Executive or Council on their selection prior to making their final decision. However, the final Awards Committee decision requires the approval of the IATDMCT Executive.
Sponsored by Siemens Healthcare Diagnostics